In breast cancer, HIF signalling has been demonstrated to result in the secretion of lysyl oxidase (LOX), LOX-like proteins (LOXL2 and 4) and exosomes, which has previously been shown to be crucial in establishing a premetastatic niche in the lungs and bones (42). This evidence concerns the gene LOX and breast cancer.